Clinical Trials Logo

Dysplasia; Hip clinical trials

View clinical trials related to Dysplasia; Hip.

Filter by:
  • None
  • Page 1

NCT ID: NCT06204068 Not yet recruiting - Dysplasia; Hip Clinical Trials

Spica Cast Duration for DDH

Start date: March 2024
Phase: N/A
Study type: Interventional

This study looks at treatment for developmental dysplasia of the hip (DDH), a condition where there is abnormal development of a child's hip joint. While spica casts are shown to very effective in treating DDH, and potentially more effective than hip braces alone, other research shows that the outcomes from braces are equivalent to those of spica casts with the added advantage of greater patient satisfaction and less burden on families. Therefore, the 12-week experimental protocol in the study, with the first 6 weeks involving the spica cast and the second 6 weeks the hip brace, was designed to determine if both treatment methods can be combined for an optimal patient experience.

NCT ID: NCT05736016 Not yet recruiting - Clinical trials for Surgical Procedure, Unspecified

Medial Wedge Insoles to Improve Gait in Persons After Total Hip Replacement

Start date: February 2024
Phase: N/A
Study type: Interventional

The study will test the hypothesis, that the use of medial wedge insoles in people participating in comprehensive rehabilitation between 1-6 months after total hip replacement, and not having a varus deformity of the knee or symptomatic arthrosis of the medial knee compartment, will improve patient's functioning, the symmetry of gait and stance compared to persons using sham insoles. The participants will undergo a 6-week program of in-patient rehabilitation aimed at: pharmacologic and non-pharmacologic pain management, improvement of vascular function, cardiopulmonary function, functions of skeletal muscles, range of motion and stability of peripheral joints, gait function, body position. The rehabilitation program will also address individual needs with psychotherapy and vocational therapy. The study will help to identify correlations between gait parameter change and functional improvement during the rehabilitation following THR. Study participants will be provided with individually made corrective medial wedge insoles or sham insoles and instructed to use them during gait training and everyday activities. Functional parameters will be examined at the study entry, at the end of 6 weeks of intervention, and 6 weeks following discharge.

NCT ID: NCT04904640 Completed - Dysplasia; Hip Clinical Trials

Biomechanical Reconstruction of Three Different Hip Stem Designs in Hip Dysplasia Using a 3D CT-based Planning Software

CTdevice
Start date: May 10, 2021
Phase:
Study type: Observational

A random population of 200 CT scans of pelvis and thigh in an adult population affected by hip dysplasia will be selected. The aim of this study is to evaluate the biomechanical reconstruction of the hip anatomy provided by three different hip stem designs in dysplastic cases, using a 3D CT based software for pre-operative planning.

NCT ID: NCT04748458 Completed - Prosthesis Survival Clinical Trials

Long-term Outcomes of Conical Tapered Stems in Cementless Total Hip Arthroplasty Due to Congenital Hip Pathologies

RetroCone
Start date: July 17, 2020
Phase:
Study type: Observational

A retrospective consecutive population of patients treated with conical tapered stems in cementless total hip arthroplasty for osteoarthritis due to congenital hip pathologies will be selected. The aim of this retrospective study is to evaluate the long-term clinical and radiographic results of this implant and the survival rates in such a specific cohort.

NCT ID: NCT03494660 Active, not recruiting - Clinical trials for Femoroacetabular Impingement

SCP Hip Outcomes Study

Start date: March 27, 2018
Phase:
Study type: Observational

Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.